MBX Biosciences Inc. (MBX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.85
Day's range
$30.53

MBX Biosciences Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2026 6.65 M $198.56 M   0.00% 18.22%
ORBIMED ADVISORS LLC 05/15/2026 3.64 M $108.59 M   -7.56% 9.97%
NEA MANAGEMENT COMPANY, LLC 05/15/2026 3.61 M $107.89 M   0.00% 9.90%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.19 M $95.28 M   -4.72% 8.74%
BLACKROCK, INC. 05/13/2026 2.94 M $87.80 M   0.74% 8.06%
FMR LLC 05/15/2026 2.94 M $87.66 M   18,550.35% 8.04%
DEEP TRACK CAPITAL, LP 05/15/2026 2.76 M $82.31 M   -15.15% 7.55%
NVP ASSOCIATES, LLC 05/15/2026 2.14 M $63.77 M   0.00% 5.85%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.62 M $48.42 M   100.00% 4.44%
BRAIDWELL LP 05/15/2026 1.49 M $44.55 M   46.52% 4.09%
05/15/2026 1.48 M $44.11 M   100.00% 4.05%
AARON WEALTH ADVISORS LLC 04/21/2026 1.17 M $34.87 M   1,568.82% 3.20%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 1.12 M $33.43 M   0.00% 3.07%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.03 M $30.72 M   22.43% 2.82%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.02 M $30.39 M   -27.69% 2.79%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 934.80 K $27.90 M   0.00% 2.56%
CITADEL ADVISORS LLC 05/15/2026 932.83 K $27.85 M   15.18% 2.56%
WOODLINE PARTNERS LP 05/15/2026 900.06 K $26.87 M   -10.00% 2.47%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 890.00 K $26.57 M   0.00% 2.44%
CALIGAN PARTNERS LP 05/15/2026 848.59 K $25.33 M   100.00% 2.32%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2026 800.04 K $23.88 M   -9.67% 2.19%
STATE STREET CORP 05/15/2026 787.21 K $23.50 M   17.02% 2.16%
ECOR1 CAPITAL, LLC 05/15/2026 777.00 K $23.19 M   -63.41% 2.13%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 670.39 K $20.02 M   3.23% 1.84%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 650.00 K $19.40 M   0.00% 1.78%
MILLENNIUM MANAGEMENT LLC 05/15/2026 564.42 K $16.85 M   22.15% 1.55%
STEMPOINT CAPITAL LP 05/18/2026 499.47 K $14.91 M   535.84% 1.37%
GOLDMAN SACHS GROUP INC 05/15/2026 457.95 K $13.67 M   37.96% 1.25%
UBS GROUP AG 05/05/2026 346.91 K $10.36 M   23.36% 0.95%
CANDRIAM S.C.A. 04/30/2026 294.37 K $8.79 M   100.00% 0.81%
05/08/2026 293.30 K $8.75 M   100.00% 0.80%
D. E. SHAW & CO., INC. 05/15/2026 288.89 K $8.62 M   -57.00% 0.79%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 287.97 K $8.60 M   1.89% 0.79%
OPALEYE MANAGEMENT INC. 05/15/2026 260.00 K $7.76 M   0.00% 0.71%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 214.91 K $6.42 M   -3.27% 0.59%
05/15/2026 211.00 K $6.30 M   0.00% 0.58%
NORTHERN TRUST CORP 05/14/2026 210.58 K $6.29 M   10.32% 0.58%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 208.05 K $6.21 M   100.00% 0.57%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 178.90 K $5.34 M   -56.25% 0.49%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2026 175.47 K $5.24 M   6.17% 0.48%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 170.15 K $5.08 M   100.00% 0.47%
GOELZER INVESTMENT MANAGEMENT, INC. 04/09/2026 164.17 K $4.90 M   -25.94% 0.45%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 150.00 K $4.48 M   -40.00% 0.41%
JPMORGAN CHASE & CO 05/13/2026 147.06 K $3.96 M   904.14% 0.40%
TFG ASSET MANAGEMENT GP LTD 05/15/2026 145.48 K $4.34 M   1.50% 0.40%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2026 123.81 K $3.70 M   -25.92% 0.34%
05/13/2026 121.52 K $3.63 M   0.00% 0.33%
TD ASSET MANAGEMENT INC 05/11/2026 116.00 K $3.46 M   14.34% 0.32%
TWO SIGMA INVESTMENTS, LP 05/15/2026 115.08 K $3.43 M   -16.96% 0.32%
BURKEHILL GLOBAL MANAGEMENT, LP 05/15/2026 100.00 K $2.99 M   0.00% 0.27%

MBX Biosciences Inc. institutional Ownership - FAQ's

During the previous two years, 168 institutional investors and hedge funds held shares of MBX Biosciences Inc.. The most heavily invested institutionals were:

Frazier Life Sciences Management, L.P.: 6.65 M

ORBIMED ADVISORS LLC: 3.64 M

NEA Management Company, LLC: 3.61 M

WELLINGTON MANAGEMENT GROUP LLP: 3.19 M

BlackRock, Inc.: 2.94 M

FMR LLC: 2.94 M

143.91% of MBX Biosciences Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 52.25 M shares in the last 24 months. This purchase volume represents approximately $1.46 B in transactions.